Technology interventions have to be targeted at the right patients and be properly explained to them, explained Joann Sciandra, RN, BSN, CCM, associate vice president of healthcare management, Geisinger Health System.
Technology interventions have to be targeted at the right patients and be properly explained to them, explained Joann Sciandra, RN, BSN, CCM, associate vice president of healthcare management, Geisinger Health System.
Transcript
What advice would you give an ACO looking to implement technology into their practice(s)?
The first advice I would give is it has to be the right patients. You just cannot turn a switch on and say every patient with heart failure is getting this, every patient post-discharge is getting B, and everybody’s getting a blood pressure cuff. It’s got to be the right patient. The other key is how you explain it to your patient. When you talk about engagement in technology, you hear some low numbers. People say 25% of the population only picked up the phone and answered the question. I believe, and I think we believe, and really our experience has served us well, that the reason is that we probably didn’t do a good job explaining it. First of all, explain that your healthcare organization is worried about you—your doctor, your hospital—and this is a way for your physician to keep an extra eye on you. So, it’s really, to me, about how we explain it to the patient and getting the right population.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More